The Effects of Micronized Progesterone and Cabergoline On a Rat Autotransplantation Endometriosis Model: A Placebo Controlled Randomized Trial

References

• Taylor H, Pal L, Seli E (eds.). Speroff’s clinical gynecologic endocrinology and infertility. Wolters Kluwer: Lippincott Williams & Wilkins; 2019. 1300 p.
   Google Scholar
• Taylor HS. Endometrial cells derived from donor stem cells in bonemarrow transplant recipients. JAMA. 2004;292(1):81–85. doi:10.1001/jama.292.1.81.
   PubMed Web of Science ®Google Scholar
• Barra F, Laganà AS, Casarin J, et al. Molecular targets for endometriosis therapy: where we are and where we are going? Int J Fertil Steril. 2019;13(2):89–92.
   PubMed Web of Science ®Google Scholar
• Sampson JA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927;1(4):422–469. doi:10.1016/S0002-9378(15)30003-X.
   Google Scholar
• Vetvicka V, Lagana AS, Salmeri FM, et al. Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives. Arch Gynecol Obstet. 2016;294(5):897–904. doi:10.1007/s00404-016-4195-6.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Capriglione S, Peterlunger I, et al. The role of oxidative stress and membrane transport systems during endometriosis: a fresh look at a busy corner. Oxid Med Cell Longev. 2018;2018:1–14. doi:10.1155/2018/7924021.
   Web of Science ®Google Scholar
• Chalhaz-Jorge C, Costa AP, Barata M, et al. Tumor necrosis factor alpha concentrations in the peritoneal fluid of infertile women with minimal to mild endometriosis are lower in patients with red lesions only than in patients without red lesions. Hum Reprod. 2003;15(6):1526–1560.
   Google Scholar
• Gazvani R, Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction. 2002;123(2):217–226. doi:10.1530/reprod/123.2.217.
   PubMed Web of Science ®Google Scholar
• Taskin MI, Gungor AC, Adali E, et al. A humanized anti-Interleukin 6 receptor monoclonal antibody, tocilizumab for the treatment of endometriosis in a rat model. Reprod Sci. 2016;23(5):662–669. doi:10.1177/1933719115612134.
   PubMed Web of Science ®Google Scholar
• Laganà AS, Vitale SG, Salmeri FM, et al. Unus pro omnibus, omnes pro uno: a novel, evidence-based, unifying theory for the pathogenesis of endometriosis. Med hypotheses. 2017;1(103):10–20. doi:10.1016/j.mehy.2017.03.032.
   Google Scholar
• Falcone T, Lebovic DI. Clinical management of endomeriosis. Obstet Gynecol. 2011;118(3):605–691. doi:10.1097/AOG.0b013e31822adfd1.
   Web of Science ®Google Scholar
• Gezer A, Oral E. Progestin therapy in endometriosis. Womens Health (Lond Engl). 2015;11(5):643–652. doi:10.2217/whe.15.42.
   PubMedGoogle Scholar
• Schweppe K-W. The current place of progestins in the treatment of endometriosis. Expert Rev Obstet Gynecol. 2012;7(2):141–148. doi:10.1586/eog.11.71.
   Google Scholar
• Rocha A, Soares R. Unraveling progesterone-induced molecular mechanisms in physiological and pathological conditions. CCP. 2009;4(2):148–153. doi:10.2174/157488409788184963.
   Google Scholar
• Hörter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev. 2001;46(1-3):75–87.
   PubMed Web of Science ®Google Scholar
• Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44(5):684–694. doi:10.1016/S0015-0282(16)48988-0.
   PubMed Web of Science ®Google Scholar
• Jammal MP, Araújo da Silva A, Martins Filho A, et al. Immunohistochemical staining of tumor necrosis factor-α and interleukin-10 in benign and malignant ovarian neoplasms. Oncol Lett. 2015;9(2):979–983. doi:10.3892/ol.2014.2781.
   PubMed Web of Science ®Google Scholar
• Bulun SE, Cheng YH, Yin P, et al. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol. 2006;248(1-2):94–103. doi:10.1016/j.mce.2005.11.041.
   PubMed Web of Science ®Google Scholar
• Singh AK, Chattopadhyay R, Chakravarty B, et al. Altered circulating levels of matrix metalloproteinases 2 and 9 and their inhibitors and effect of progesterone supplementation in women with endometriosis undergoing in vitro fertilization. Fertil Steril. 2013;100(1):127–134. 1doi:10.1016/j.fertnstert.2013.03.006.
   PubMed Web of Science ®Google Scholar
• Boelig RC, Della Corte L, Ashoush S, et al. Oral progesterone for the prevention of recurrent preterm birth: systematic review and metaanalysis. Am J Obstet Gynecol MFM. 2019;1(1):50–62.
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R. Non-clinical studies of progesterone. Climacteric. 2018;21(4):315–320. doi:10.1080/13697137.2018.1463982.
   Google Scholar
• Groothuis PG, Nap AW, Winterhager E, et al. Vascular development in endometriosis. Angiogenesis. 2005;8(2):147–156. doi:10.1007/s10456-005-9005-x.
   PubMedGoogle Scholar
• Taylor RN, Yu J, Torres PB, et al. Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci. 2009;16(2):140–146. doi:10.1177/1933719108324893.
   PubMed Web of Science ®Google Scholar
• Becker CM, D’Amato RJ. Angiogenesis and antiangiogenetic therapy in endometriosis. Microvasc Res. 2007;74(2-3):121–130. doi:10.1016/j.mvr.2007.04.008.
   PubMed Web of Science ®Google Scholar
• Chakroborty D, Chowdhury UR, Sarkar C, et al. Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization. J Clin Invest. 2008;118(4):1380–1389. doi:10.1172/JCI33125.
   PubMed Web of Science ®Google Scholar
• Basu S, Nagy JA, Pal S, et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med. 2001;7(5):569–574. doi:10.1038/87895.
   PubMed Web of Science ®Google Scholar
• Novella-Maestre E, Carda C, Noguera I, et al. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Hum Reprod. 2009;24(5):1025–1035. doi:10.1093/humrep/den499.
   PubMed Web of Science ®Google Scholar
• Novella-Maestre E, Carda C, Ruiz-Sauri A, et al. Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy. Biol Reprod. 2010;83(5):866–873. doi:10.1095/biolreprod.110.084392.
   PubMed Web of Science ®Google Scholar
• Ercan CM, Kayaalp O, Cengiz M, et al. Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model. Arch Gynecol Obstet. 2015;291(5):1103–1111. doi:10.1007/s00404-014-3524-x.
   PubMed Web of Science ®Google Scholar
• Hamid AM, Madkour WA, Moawad A, Elzaher MA, et al. Does cabergoline help in decreasing endometrioma size compared to LHRH agonist? A prospective randomized study. Arch Gynecol Obstet. 2014;290(4):677–682. doi:10.1007/s00404-014-3242-4.
   PubMed Web of Science ®Google Scholar
• Hyder SM, Stancel GM. Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol Endocrinol. 1999;13(6):806–811. doi:10.1210/mend.13.6.0308.
   PubMed Web of Science ®Google Scholar
• D’Hooghe TM, Kyama CK, Mwenda JM. Baboon model for endometriosis. Baboon Biomed Res. 2009;139–156.
   Google Scholar